• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Maged1 缺乏可减轻小鼠帕金森病的进展。

The deficiency of Maged1 attenuates Parkinson's disease progression in mice.

机构信息

Department of Neurobiology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, China.

SKL of Pharmaceutical Biotechnology and Model Animal Research Center, Collaborative Innovation Center for Genetics and Development, Nanjing Biomedical Research Institute, Nanjing University, Nanjing, 210061, China.

出版信息

Mol Brain. 2023 Feb 11;16(1):22. doi: 10.1186/s13041-023-01011-3.

DOI:10.1186/s13041-023-01011-3
PMID:36774489
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9921624/
Abstract

Melanoma-associated antigen D1 (Maged1) has critical functions in the central nervous system in both developmental and adult stages. Loss of Maged1 in mice has been linked to depression, cognitive disorder, and drug addiction. However, the role of Maged1 in Parkinson's disease (PD) remains unclear. In this study, we observed that Maged1 was expressed in the dopaminergic (DA) neurons of the substantia nigra in mice and humans, which could be upregulated by the in vivo or in vitro treatment with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) or 1-Methyl-4-phenylpyridinium iodide (MPP). Genetic ablation of Maged1 in mice attenuated motor deficits, the loss of DA neurons, and disease progression induced by MPTP. Moreover, Maged1 deficiency protected DA neurons against MPP-induced toxicity in primary cultured cells. Mechanistically, loss of Maged1 upregulated the Akt signaling pathway and downregulated the mTOR signaling pathway in SH-SY5Y cells, which may in turn attenuate the cell apoptosis and impairment of autophagy. Consistent with it, the degeneration of midbrain and striatum among elderly Maged1 knockout mice was relatively mild compared to those in wild-type mice under physiological conditions. Taken together, this study suggested that Maged1 deficiency inhibited apoptosis and enhanced autophagy, which may provide a new potential target for the therapy of PD.

摘要

黑色素瘤相关抗原 D1(Maged1)在中枢神经系统的发育和成年阶段都具有关键功能。在小鼠中缺失 Maged1 与抑郁、认知障碍和药物成瘾有关。然而,Maged1 在帕金森病(PD)中的作用尚不清楚。在这项研究中,我们观察到 Maged1 在小鼠和人类的黑质多巴胺能(DA)神经元中表达,并且可以通过体内或体外用 1-甲基-4-苯基-1,2,3,6-四氢吡啶(MPTP)或 1-甲基-4-苯基吡啶碘化物(MPP)处理而上调。在小鼠中敲除 Maged1 可减轻 MPTP 诱导的运动缺陷、DA 神经元丢失和疾病进展。此外,Maged1 缺乏可保护原代培养细胞免受 MPP 诱导的毒性。在机制上,Maged1 缺失可上调 SH-SY5Y 细胞中的 Akt 信号通路并下调 mTOR 信号通路,这可能反过来减轻细胞凋亡和自噬受损。与之一致的是,与野生型小鼠相比,老年 Maged1 敲除小鼠的中脑和纹状体退化在生理条件下相对较轻。总之,这项研究表明,Maged1 缺乏抑制细胞凋亡并增强自噬,这可能为 PD 的治疗提供新的潜在靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5710/9921624/041dd56edc25/13041_2023_1011_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5710/9921624/767c59a2d890/13041_2023_1011_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5710/9921624/32d07b15c6df/13041_2023_1011_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5710/9921624/2224677b2b2d/13041_2023_1011_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5710/9921624/8a8eccd2d11b/13041_2023_1011_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5710/9921624/4487bf90a270/13041_2023_1011_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5710/9921624/c369117ed442/13041_2023_1011_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5710/9921624/041dd56edc25/13041_2023_1011_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5710/9921624/767c59a2d890/13041_2023_1011_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5710/9921624/32d07b15c6df/13041_2023_1011_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5710/9921624/2224677b2b2d/13041_2023_1011_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5710/9921624/8a8eccd2d11b/13041_2023_1011_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5710/9921624/4487bf90a270/13041_2023_1011_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5710/9921624/c369117ed442/13041_2023_1011_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5710/9921624/041dd56edc25/13041_2023_1011_Fig7_HTML.jpg

相似文献

1
The deficiency of Maged1 attenuates Parkinson's disease progression in mice.Maged1 缺乏可减轻小鼠帕金森病的进展。
Mol Brain. 2023 Feb 11;16(1):22. doi: 10.1186/s13041-023-01011-3.
2
Vitexin protects dopaminergic neurons in MPTP-induced Parkinson's disease through PI3K/Akt signaling pathway.牡荆素通过PI3K/Akt信号通路保护MPTP诱导的帕金森病中的多巴胺能神经元。
Drug Des Devel Ther. 2018 Mar 16;12:565-573. doi: 10.2147/DDDT.S156920. eCollection 2018.
3
Neuroprotective Effects of the DPP4 Inhibitor Vildagliptin in In Vivo and In Vitro Models of Parkinson's Disease.DPP4 抑制剂维格列汀在帕金森病体内和体外模型中的神经保护作用。
Int J Mol Sci. 2022 Feb 21;23(4):2388. doi: 10.3390/ijms23042388.
4
Orexin B protects dopaminergic neurons from 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity associated with reduced extracellular signal-regulated kinase phosphorylation.食欲素 B 可减少细胞外信号调节激酶磷酸化,从而保护多巴胺能神经元免受 1-甲基-4-苯基-1,2,3,6-四氢吡啶诱导的神经毒性。
Mol Biol Rep. 2024 May 24;51(1):669. doi: 10.1007/s11033-024-09587-2.
5
Artemisia Leaf Extract protects against neuron toxicity by TRPML1 activation and promoting autophagy/mitophagy clearance in both in vitro and in vivo models of MPP+/MPTP-induced Parkinson's disease.青蒿叶提取物通过激活 TRPML1 并促进自噬/线粒体自噬清除,在 MPP+/MPTP 诱导的帕金森病的体外和体内模型中发挥保护神经元毒性的作用。
Phytomedicine. 2022 Sep;104:154250. doi: 10.1016/j.phymed.2022.154250. Epub 2022 Jun 15.
6
Teaghrelin protected dopaminergic neurons in MPTP-induced Parkinson's disease animal model by promoting PINK1/Parkin-mediated mitophagy and AMPK/SIRT1/PGC1-α-mediated mitochondrial biogenesis.Teaghrelin 通过促进 PINK1/Parkin 介导的线粒体自噬和 AMPK/SIRT1/PGC1-α 介导的线粒体生物发生来保护 MPTP 诱导的帕金森病动物模型中的多巴胺能神经元。
Environ Toxicol. 2024 Jul;39(7):4022-4034. doi: 10.1002/tox.24275. Epub 2024 Apr 15.
7
Amentoflavone protects dopaminergic neurons in MPTP-induced Parkinson's disease model mice through PI3K/Akt and ERK signaling pathways.穗花杉双黄酮通过PI3K/Akt和ERK信号通路保护MPTP诱导的帕金森病模型小鼠中的多巴胺能神经元。
Toxicol Appl Pharmacol. 2017 Mar 15;319:80-90. doi: 10.1016/j.taap.2017.01.019. Epub 2017 Feb 7.
8
EriB targeted inhibition of microglia activity attenuates MPP induced DA neuron injury through the NF-κB signaling pathway.EriB 通过 NF-κB 信号通路靶向抑制小胶质细胞活性,减轻 MPP 诱导的 DA 神经元损伤。
Mol Brain. 2018 Dec 18;11(1):75. doi: 10.1186/s13041-018-0418-z.
9
SNHG1 promotes MPP-induced cytotoxicity by regulating PTEN/AKT/mTOR signaling pathway in SH-SY5Y cells via sponging miR-153-3p.SNHG1 通过海绵吸附 miR-153-3p 调控 PTEN/AKT/mTOR 信号通路促进 MPP+诱导的 SH-SY5Y 细胞毒性。
Biol Res. 2020 Jan 6;53(1):1. doi: 10.1186/s40659-019-0267-y.
10
Association Between Decreased Srpk3 Expression and Increased Substantia Nigra Alpha-Synuclein Level in an MPTP-Induced Parkinson's Disease Mouse Model.MPTP诱导的帕金森病小鼠模型中Srpk3表达降低与黑质α-突触核蛋白水平升高之间的关联
Mol Neurobiol. 2023 Feb;60(2):780-788. doi: 10.1007/s12035-022-03104-x. Epub 2022 Nov 12.

引用本文的文献

1
Correction: The deficiency of Maged1 attenuates Parkinson's disease progression in mice.更正:Maged1的缺乏可减缓小鼠帕金森病的进展。
Mol Brain. 2024 Feb 9;17(1):6. doi: 10.1186/s13041-023-01075-1.
2
SGLT2 inhibitor empagliflozin alleviates cardiac remodeling and contractile anomalies in a FUNDC1-dependent manner in experimental Parkinson's disease.SGLT2 抑制剂恩格列净以 FUNDC1 依赖的方式减轻实验性帕金森病中的心脏重构和收缩异常。
Acta Pharmacol Sin. 2024 Jan;45(1):87-97. doi: 10.1038/s41401-023-01144-0. Epub 2023 Sep 7.

本文引用的文献

1
Autophagy and Parkinson's Disease.自噬与帕金森病。
Adv Exp Med Biol. 2020;1207:21-51. doi: 10.1007/978-981-15-4272-5_2.
2
Neuroinflammatory Responses and Parkinson' Disease: Pathogenic Mechanisms and Therapeutic Targets.神经炎症反应与帕金森病:发病机制与治疗靶点。
J Neuroimmune Pharmacol. 2020 Dec;15(4):830-837. doi: 10.1007/s11481-020-09926-7. Epub 2020 Jun 11.
3
Targeting autophagy-related protein kinases for potential therapeutic purpose.靶向自噬相关蛋白激酶以实现潜在治疗目的。
Acta Pharm Sin B. 2020 Apr;10(4):569-581. doi: 10.1016/j.apsb.2019.10.003. Epub 2019 Oct 18.
4
Ferroptosis was more initial in cell death caused by iron overload and its underlying mechanism in Parkinson's disease.铁过载引起的细胞死亡中,铁死亡更为初始,其在帕金森病中的潜在机制也是如此。
Free Radic Biol Med. 2020 May 20;152:227-234. doi: 10.1016/j.freeradbiomed.2020.03.015. Epub 2020 Mar 23.
5
Novel compounds for the modulation of mTOR and autophagy to treat neurodegenerative diseases.用于调节 mTOR 和自噬以治疗神经退行性疾病的新型化合物。
Cell Signal. 2020 Jan;65:109442. doi: 10.1016/j.cellsig.2019.109442. Epub 2019 Oct 19.
6
Current Progress of Mitochondrial Quality Control Pathways Underlying the Pathogenesis of Parkinson's Disease.帕金森病发病机制中线粒体质量控制途径的研究进展。
Oxid Med Cell Longev. 2019 Aug 14;2019:4578462. doi: 10.1155/2019/4578462. eCollection 2019.
7
Autophagy Stimulation Decreases Dopaminergic Neuronal Death Mediated by Oxidative Stress.自噬刺激可减少氧化应激介导的多巴胺能神经元死亡。
Mol Neurobiol. 2019 Dec;56(12):8136-8156. doi: 10.1007/s12035-019-01654-1. Epub 2019 Jun 13.
8
Balancing mTOR Signaling and Autophagy in the Treatment of Parkinson's Disease.平衡 mTOR 信号和自噬在帕金森病治疗中的作用。
Int J Mol Sci. 2019 Feb 8;20(3):728. doi: 10.3390/ijms20030728.
9
Therapeutic activation of autophagy by combined treatment with rapamycin and trehalose in a mouse MPTP-induced model of Parkinson's disease.雷帕霉素和海藻糖联合治疗在 MPTP 诱导的帕金森病小鼠模型中诱导自噬的治疗作用。
Pharmacol Biochem Behav. 2019 Feb;177:1-11. doi: 10.1016/j.pbb.2018.12.005. Epub 2018 Dec 21.
10
Balancing Apoptosis and Autophagy for Parkinson's Disease Therapy: Targeting BCL-2.平衡细胞凋亡和自噬治疗帕金森病:靶向 BCL-2。
ACS Chem Neurosci. 2019 Feb 20;10(2):792-802. doi: 10.1021/acschemneuro.8b00356. Epub 2019 Feb 11.